bf/NASDAQ:BNTC_icon.png

COM:BENITEC

Benitec Biopharma Inc.

  • Stock

USD

Last Close

10.20

22/11 21:00

Market Cap

89.46M

Beta: -

Volume Today

22.17K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Jun '14
Jun '15
Jun '16
Jun '17
Jun '18
Jun '19
Jun '20
Jun '21
Jun '22
Jun '23
Jun '24
average inventory
2.55M
-
2.37M
7.08%
1.12M
52.76%
23.10K
97.94%
-32.53K
240.82%
-0.00
100.00%
474K
94,777,211,280,546.92%
474K
0%
6.50K
-
38K
484.62%
average payables
619.23K
-
649.23K
4.84%
492.34K
24.16%
267.74K
45.62%
279.89K
4.54%
1.46M
421.01%
1.39M
4.94%
581K
58.09%
1.38M
137.52%
1.51M
9.42%
1.25M
17.52%
average receivables
113.57K
-
152.24K
34.05%
459.14K
201.59%
2.06M
348.16%
3.26M
58.22%
2.83M
13.11%
1.30M
54.20%
42K
96.76%
14K
66.67%
29K
107.14%
142K
389.66%
book value per share
3.97K
-
808.66
79.63%
504.13
37.66%
480.44
4.70%
333.68
30.55%
19.34
94.20%
10.03
48.16%
4.66
53.53%
0.35
92.43%
0.15
58.67%
11.64
7,883.49%
capex per share
-83.97
-
-17.10
79.63%
-9.15
46.48%
-3.82
58.26%
-1.48
61.32%
-0.47
68.13%
-0.09
80.24%
-0.05
44.69%
-0.00
96.91%
-0.00
54.64%
0.04
6,209.61%
capex to depreciation
-0.61
-
-0.25
-
-0.52
105.20%
-0.03
93.64%
-0.00
92.09%
0.52
19,983.09%
capex to operating cash flow
0.05
-
0.04
18.53%
0.01
68.38%
0.02
25.21%
0.01
54.94%
0.01
-
0.02
36.60%
0.00
95.25%
0.00
93.21%
-0.01
16,716.75%
capex to revenue
-0.47
-
-0.47
0.00%
-0.74
57.78%
-0.29
60.41%
-0.13
54.12%
-0.04
73.37%
-0.98
2,647.54%
-3.75
282.46%
-0.18
95.25%
-0.01
92.51%
cash per share
3.62K
-
737.84
79.63%
487.88
33.88%
390.39
19.98%
286.88
26.52%
18.47
93.56%
9.60
48.03%
4.60
52.05%
0.50
89.20%
1.79
259.58%
12.53
600.91%
days of inventory on hand
25.31K
-
25.31K
0.00%
391.26
98.45%
-113.62
129.04%
-0.00
100.00%
-1.87K
-
days payables outstanding
6.94K
-
6.94K
0.00%
1.41K
79.63%
233.49
83.47%
469.40
101.03%
2.13K
354.04%
-556.38
126.11%
2.61K
569.35%
76.24K
2,819.70%
days sales outstanding
41.53
-
83.06
100.00%
768.55
825.27%
2.74K
257.08%
2.50K
8.72%
81.68
96.74%
222.01
171.81%
154.66
30.34%
15
90.30%
267.67
1,684.44%
debt to assets
0.03
-
0.01
71.50%
0.14
1,262.81%
0.13
7.77%
0.01
95.66%
debt to equity
0.04
-
0.01
73.09%
0.28
2,543.59%
2.77
883.41%
0.01
99.78%
dividend yield
0.02
-
earnings yield
-0.32
-
-0.11
66.22%
-1.54
1,310.43%
-0.21
86.54%
-0.30
44.67%
0.01
104.08%
-0.06
594.58%
-0.04
26.54%
-0.12
159.40%
-3.48
2,918.39%
-0.76
78.17%
enterprise value
13.05M
-
64.23M
392.35%
-1.58M
102.47%
7.76M
590.05%
16.73M
115.45%
218.88M
1,208.71%
127.92M
41.56%
290.79M
127.31%
157.89M
45.70%
3.71M
97.65%
-21.11M
669.11%
enterprise value over ebitda
-1.32
-
-9.03
585.40%
0.12
101.31%
-2.05
1,836.73%
-1.99
3.01%
101.44
5,201.03%
-16.36
116.13%
-21.90
33.83%
-8.80
59.79%
-0.20
97.75%
0.94
573.96%
ev to operating cash flow
-1.35
-
-6.63
392.35%
0.08
101.18%
-0.93
1,292.54%
-1.96
109.23%
-16.98
-
-22.66
33.48%
-9.93
56.18%
-0.21
97.93%
1.09
628.31%
ev to sales
12.82
-
77.47
504.36%
-4.57
105.90%
17.24
477.08%
36.72
113.02%
19.34
47.33%
1.32K
6,718.47%
4.93K
273.72%
2.16K
56.11%
49.45
97.71%
free cash flow per share
-1.80K
-
-445.04
75.22%
-733.35
64.78%
-245.23
66.56%
-208.69
14.90%
-0.47
99.77%
-7.47
1,486.89%
-3.04
59.33%
-1.95
35.92%
-13.00
567.52%
-4.82
62.90%
free cash flow yield
-0.30
-
-0.12
58.90%
-1.70
1,266.07%
-0.40
76.51%
-0.30
24.47%
-0.00
99.43%
-0.06
3,131.11%
-0.04
24.30%
-0.10
134.77%
-3.20
3,142.26%
-0.66
79.25%
graham net net
3.60K
-
735.45
79.55%
481.30
34.56%
437.35
9.13%
297.49
31.98%
17.61
94.08%
8.78
50.11%
4.29
51.18%
0.12
97.22%
-1.25
1,152.55%
11.36
1,005.87%
graham number
13.08K
-
2.66K
79.63%
2.74K
2.99%
1.17K
57.26%
1.25K
6.40%
38.16
96.94%
42.82
12.21%
18.34
57.18%
4.25
76.85%
6.80
60.26%
37.98
458.22%
income quality
0.89
-
1.10
22.75%
1.09
0.53%
1.90
73.90%
1
47.34%
0.91
-
0.92
1.50%
0.87
5.54%
0.92
5.45%
0.89
3.12%
intangibles to total assets
0
-
0
0
0
0
0
0
0
0
0
0
interest coverage
2.27K
-
-557.94
124.62%
-578.21
3.63%
-24.88
95.70%
interest debt per share
0.40
-
0.05
87.85%
0.10
114.07%
0.43
314.09%
0.29
31.51%
inventory turnover
0.01
-
0.01
0.00%
0.93
6,369.56%
-3.21
444.35%
-331.22B
10,310,593,395,792.81%
-0.20
-
invested capital
0.04
-
0.01
73.09%
0.28
2,543.59%
2.77
883.41%
47.20M
1,705,580,937.57%
market cap
33.56M
-
80.94M
141.20%
12.03M
85.14%
21.11M
75.52%
28.54M
35.17%
234.58M
721.90%
137.32M
41.46%
310.34M
126.00%
161.15M
48.08%
5.63M
96.51%
29.48M
423.90%
net current asset value
22.05M
-
17.96M
18.53%
13.69M
23.80%
16.14M
17.90%
13.44M
16.70%
16.09M
19.70%
9.46M
41.21%
19.24M
103.37%
1.73M
91.01%
-533K
130.83%
46.71M
8,863.98%
net debt to ebitda
2.07
-
2.35
13.41%
1.01
56.83%
3.53
247.58%
1.40
60.16%
-7.27
617.75%
1.20
116.52%
1.47
22.54%
0.18
87.69%
0.10
43.51%
2.25
2,096.32%
net income per share
-1.91K
-
-389.77
79.63%
-663.12
70.13%
-127.11
80.83%
-207.21
63.01%
3.35
101.62%
-8.13
342.90%
-3.21
60.53%
-2.27
29.20%
-14.12
521.43%
-5.51
60.97%
operating cash flow per share
-1.71K
-
-427.94
75%
-724.20
69.23%
-241.41
66.67%
-207.21
14.17%
-7.38
-
-2.99
59.51%
-1.95
34.87%
-13.00
568.03%
-4.78
63.23%
payables turnover
0.05
-
0.05
0.00%
0.26
390.89%
1.56
505.04%
0.78
50.26%
0.17
77.98%
-0.66
483.06%
0.14
121.31%
0.00
96.57%
receivables turnover
8.79
-
4.39
50.00%
0.47
89.19%
0.13
72.00%
0.15
9.56%
4.47
2,966.86%
1.64
63.21%
2.36
43.55%
24.33
931.07%
1.36
94.40%
research and ddevelopement to revenue
5.76
-
5.76
0.00%
28.64
397.03%
11.82
58.73%
11.11
5.96%
0.19
98.27%
30.94
16,005.98%
118.98
284.58%
154.41
29.78%
170.32
10.30%
return on tangible assets
-0.45
-
-0.45
0.00%
-1.25
176.23%
-0.25
79.85%
-0.55
117.29%
0.15
127.37%
-0.72
579.93%
-0.64
10.02%
-3.11
382.10%
-4.38
41.01%
-0.43
90.22%
revenue per share
179.75
-
36.61
79.63%
12.42
66.08%
13.09
5.42%
11.04
15.69%
13.21
19.68%
0.09
99.28%
0.01
85.54%
0.01
34.96%
0.05
505.82%
roe
-0.48
-
-0.48
0.00%
-1.32
172.91%
-0.26
79.89%
-0.62
134.71%
0.17
127.86%
-0.81
568.58%
-0.69
15.06%
-6.44
835.18%
-96.84
1,403.60%
-0.47
99.51%
roic
-0.40
-
-0.80
97.83%
-0.91
14.55%
-1.01
10.81%
-0.62
38.48%
0.16
125.32%
-0.75
578.02%
-0.66
12.17%
-4.04
511.87%
-14.46
257.76%
-0.47
96.73%
sales general and administrative to revenue
7.53
-
7.44
1.19%
25.86
247.54%
15.52
39.99%
14.07
9.33%
0.59
95.82%
57.39
9,653.82%
110.37
92.31%
91.04
17.51%
85.09
6.53%
shareholders equity per share
3.97K
-
808.66
79.63%
504.13
37.66%
480.44
4.70%
333.68
30.55%
19.34
94.20%
10.03
48.16%
4.66
53.53%
0.35
92.43%
0.15
58.67%
11.64
7,883.49%
stock based compensation to revenue
0.86
-
2.44
-
10.75
339.81%
11.92
10.91%
6.03
49.43%
tangible asset value
22.48M
-
18.31M
18.53%
14.07M
23.19%
16.53M
17.48%
13.77M
16.68%
16.57M
20.34%
10.24M
38.21%
20.01M
95.45%
2.88M
85.60%
202K
92.99%
47.25M
23,290.10%
tangible book value per share
3.97K
-
808.66
79.63%
504.13
37.66%
480.44
4.70%
333.68
30.55%
19.34
94.20%
10.03
48.16%
4.66
53.53%
0.35
92.43%
0.15
58.67%
11.64
7,883.49%
working capital
22.05M
-
17.96M
18.53%
13.70M
23.72%
16.17M
17.98%
13.48M
16.63%
16.09M
19.39%
9.67M
39.89%
19.24M
98.89%
2.29M
88.11%
-249K
110.88%
46.75M
18,875.10%

All numbers in USD (except ratios and percentages)